Burden and Outcomes of Heart Failure Hospitalizations in Adults With Chronic Kidney Disease.


Journal

Journal of the American College of Cardiology
ISSN: 1558-3597
Titre abrégé: J Am Coll Cardiol
Pays: United States
ID NLM: 8301365

Informations de publication

Date de publication:
04 06 2019
Historique:
received: 23 11 2018
revised: 19 02 2019
accepted: 26 02 2019
entrez: 1 6 2019
pubmed: 31 5 2019
medline: 3 4 2020
Statut: ppublish

Résumé

Data on rates of heart failure (HF) hospitalizations, recurrent hospitalizations, and outcomes related to HF hospitalizations in chronic kidney disease (CKD) are limited. This study examined rates of HF hospitalizations and re-hospitalizations within a large CKD population and evaluated the burden of HF hospitalizations with the risk of subsequent CKD progression and death. The prospective CRIC (Chronic Renal Insufficiency Cohort) study measured the estimated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (ACR) at baseline. The crude rates and rate ratios of HF hospitalizations and 30-day HF re-hospitalizations were calculated using Poisson regression models. Cox regression was used to assess the association of the frequency of HF hospitalizations within the first 2 years of follow-up with risk of subsequent CKD progression and death. Among 3,791 participants, the crude rate of HF admissions was 5.8 per 100 person-years (with higher rates of HF with preserved ejection fraction vs. HF with reduced ejection fraction). The adjusted rate of HF was higher with a lower eGFR (vs. eGFR >45 ml/min/1.73 m Within a large U.S. CKD population, the rates of HF hospitalizations and re-hospitalization were high, with even higher rates across categories of lower eGFR and higher urine ACR. Patients with CKD hospitalized with HF had greater risks of CKD progression and death. HF prevention and treatment should be a public health priority to improve CKD outcomes.

Sections du résumé

BACKGROUND
Data on rates of heart failure (HF) hospitalizations, recurrent hospitalizations, and outcomes related to HF hospitalizations in chronic kidney disease (CKD) are limited.
OBJECTIVES
This study examined rates of HF hospitalizations and re-hospitalizations within a large CKD population and evaluated the burden of HF hospitalizations with the risk of subsequent CKD progression and death.
METHODS
The prospective CRIC (Chronic Renal Insufficiency Cohort) study measured the estimated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (ACR) at baseline. The crude rates and rate ratios of HF hospitalizations and 30-day HF re-hospitalizations were calculated using Poisson regression models. Cox regression was used to assess the association of the frequency of HF hospitalizations within the first 2 years of follow-up with risk of subsequent CKD progression and death.
RESULTS
Among 3,791 participants, the crude rate of HF admissions was 5.8 per 100 person-years (with higher rates of HF with preserved ejection fraction vs. HF with reduced ejection fraction). The adjusted rate of HF was higher with a lower eGFR (vs. eGFR >45 ml/min/1.73 m
CONCLUSIONS
Within a large U.S. CKD population, the rates of HF hospitalizations and re-hospitalization were high, with even higher rates across categories of lower eGFR and higher urine ACR. Patients with CKD hospitalized with HF had greater risks of CKD progression and death. HF prevention and treatment should be a public health priority to improve CKD outcomes.

Identifiants

pubmed: 31146814
pii: S0735-1097(19)34692-3
doi: 10.1016/j.jacc.2019.02.071
pmc: PMC6590908
mid: NIHMS1528036
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2691-2700

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK072231
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002548
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK060980
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK060963
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR024131
Pays : United States
Organisme : NCRR NIH HHS
ID : M01 RR013987
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000003
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000439
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK060990
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002240
Pays : United States
Organisme : NIDDK NIH HHS
ID : L30 DK110819
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK092949
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR029879
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK061028
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000433
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK060984
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK061021
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK061022
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK103612
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000424
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL141846
Pays : United States
Organisme : NCRR NIH HHS
ID : M01 RR016500
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM109036
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK060902
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002003
Pays : United States

Investigateurs

Lawrence J Appel (LJ)
Harold I Feldman (HI)
Alan S Go (AS)
Jiang He (J)
James P Lash (JP)
Panduranga S Rao (PS)
Mahboob Rahman (M)
Raymond R Townsend (RR)

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Références

J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S148-53
pubmed: 12819321
N Engl J Med. 2004 Sep 23;351(13):1296-305
pubmed: 15385656
Heart. 2007 Sep;93(9):1046-50
pubmed: 17277352
Clin Chem. 2007 Apr;53(4):766-72
pubmed: 17332152
J Am Soc Nephrol. 2007 Apr;18(4):1307-15
pubmed: 17344421
J Am Coll Cardiol. 2008 Aug 5;52(6):428-34
pubmed: 18672162
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Clin J Am Soc Nephrol. 2009 Aug;4(8):1302-11
pubmed: 19541818
Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):407-13
pubmed: 20031870
Am J Nephrol. 2010;31(5):426-34
pubmed: 20389058
JAMA. 2010 May 5;303(17):1716-22
pubmed: 20442387
Am Heart J. 2010 Nov;160(5):885-92
pubmed: 21095276
J Card Fail. 2011 Jan;17(1):54-75
pubmed: 21187265
JAMA. 2013 Feb 13;309(6):587-93
pubmed: 23403683
Clin J Am Soc Nephrol. 2013 Mar;8(3):355-62
pubmed: 23411431
J Am Coll Cardiol. 2013 Mar 26;61(12):1259-67
pubmed: 23500328
Circ Cardiovasc Qual Outcomes. 2013 May 1;6(3):333-42
pubmed: 23685625
Circulation. 2014 Jan 21;129(3):e28-e292
pubmed: 24352519
J Am Soc Nephrol. 2015 Mar;26(3):715-22
pubmed: 25190730
Clin J Am Soc Nephrol. 2015 Feb 6;10(2):205-14
pubmed: 25605700
J Am Soc Nephrol. 2015 Dec;26(12):3141-50
pubmed: 25855772
JAMA Cardiol. 2017 Mar 1;2(3):314-318
pubmed: 28002548
Eur J Heart Fail. 2017 May;19(5):615-623
pubmed: 28217978
J Am Heart Assoc. 2017 May 17;6(5):null
pubmed: 28515118
JAMA. 2017 Jul 18;318(3):270-278
pubmed: 28719692
Circ Heart Fail. 2017 Aug;10(8):
pubmed: 28765150
Circulation. 2018 Jul 3;138(1):12-24
pubmed: 29519849
Am J Cardiol. 2018 Jul 1;122(1):108-114
pubmed: 29703442
Am J Kidney Dis. 2018 Sep;72(3):390-399
pubmed: 29784617
J Card Fail. 2018 Dec;24(12):835-841
pubmed: 30012360
Am J Med Qual. 2019 Mar/Apr;34(2):127-135
pubmed: 30024279
Telemed J E Health. 2019 Jun;25(6):447-454
pubmed: 30036166
Circulation. 1993 Jul;88(1):107-15
pubmed: 8319323

Auteurs

Nisha Bansal (N)

Department of Medicine, University of Washington, Seattle, Washington. Electronic address: nbansal@nephrology.washington.edu.

Leila Zelnick (L)

Department of Medicine, University of Washington, Seattle, Washington.

Zeenat Bhat (Z)

Department of Medicine, Wayne State University, Detroit, Michigan.

Mirela Dobre (M)

Department of Medicine, Case Western Reserve University, University Hospitals Case Medical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio.

Jiang He (J)

Department of Medicine, Tulane University, New Orleans, Louisiana.

James Lash (J)

Department of Medicine, Jesse Brown VAMC and University of Illinois Hospital and Health Sciences Center, Chicago, Illinois.

Bernard Jaar (B)

Department of Medicine, Johns Hopkins University, Baltimore, Maryland.

Rupal Mehta (R)

Department of Medicine, Northwestern University, Evanston, Illinois.

Dominic Raj (D)

Department of Medicine, George Washington University, Washington, DC.

Hernan Rincon-Choles (H)

Department of Medicine, Cleveland Clinic, Cleveland, Ohio.

Milda Saunders (M)

Department of Medicine, University of Chicago, Chicago, Illinois.

Sarah Schrauben (S)

Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Matthew Weir (M)

Department of Medicine, University of Maryland, College Park, Maryland.

Julie Wright (J)

Department of Medicine, University of Michigan, Ann Arbor, Michigan.

Alan S Go (AS)

Department of Medicine, Kaiser Permanente Northern California, Division of Research, Oakland, California; Department of Medicine, University of California-San Francisco, San Francisco, California; Department of Medicine, Stanford University School of Medicine, Palo Alto, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH